Safety and Pharmacokinetics of IgPro20 and IgPro10 in Adults With Systemic Sclerosis (SSc)

NCT04137224 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Diffuse Cutaneous Systemic Sclerosis

Interventions

BIOLOGICAL: IgPro20
BIOLOGICAL: IgPro10

Sponsor

CSL Behring